ACCESS TO MEDICINE FOUNDATION | This is the third Benchmark report on AMR. In this report, Access to Medicine Foundation takes a look at how pharmaceutical companies are responding to drug resistance. One major takeaway from the report: access to antibiotics in LMICs is the biggest challenge large pharma is facing.